Jefferies Group LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Sep 21, 2023	BUY	$31.82 - $40.75 $986,420 - $1.26 Million	31,000 New	31,000 $1.25 Million
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $986,420 - $1.26 Million	31,000 New	31,000 $1.25 Million
Q3 2019 Nov 13, 2019	SELL	$15.2 - $17.69 $1.43 Million - $1.66 Million	-93,800 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $1.13 Million - $1.32 Million	76,600 Added 445.35%	93,800 $1.61 Million
Q3 2017 Nov 14, 2017	BUY	$11.76 - $17.4 $202,272 - $299,280	17,200	17,200 $299,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.